Clinical Study of IM96 CAR-T Cell Therapy in Patients With Advanced Adenocarcinoma of Gastric/Esophagogastric Junction

NCT07406984 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Adenocarcinoma of Gastric
Adenocarcinoma of Esophagogastric Junction

Interventions

BIOLOGICAL: IM96 CAR-T Cells

Sponsor

Beijing Immunochina Medical Science & Technology Co., Ltd.

Collaborators

[object Object]